FDA OKs new Novartis drug for type of advanced breast cancer - WFMJ.com News weather sports for Youngstown-Warren Ohio

FDA OKs new Novartis drug for type of advanced breast cancer

Posted: Updated:
  • NationalMore>>

  • Authorities: Flash flood surges through Maryland community

    Authorities: Flash flood surges through Maryland community

    Sunday, May 27 2018 9:15 PM EDT2018-05-28 01:15:29 GMT
    (Libby Solomon/The Baltimore Sun via AP). Water rushes through Main Street in Ellicott City, Md., Sunday, May 27, 2018. Flash flooding and water rescues are being reported in Maryland as heavy rain soaks much of the state.(Libby Solomon/The Baltimore Sun via AP). Water rushes through Main Street in Ellicott City, Md., Sunday, May 27, 2018. Flash flooding and water rescues are being reported in Maryland as heavy rain soaks much of the state.
    Roaring flash flood engulfs downtown Ellicott City, Maryland, which was hit by similar devastation in 2016 floods.More >>
    Roaring flash flood engulfs downtown Ellicott City, Maryland, which was hit by similar devastation in 2016 floods.More >>
  • George H.W. Bush hospitalized in Maine

    George H.W. Bush hospitalized in Maine

    Sunday, May 27 2018 9:14 PM EDT2018-05-28 01:14:57 GMT
    A spokesman for former President George H.W. Bush says the 93-year-old was experiencing low blood pressure and has been hospitalized.More >>
    A spokesman for former President George H.W. Bush says the 93-year-old was experiencing low blood pressure and has been hospitalized.More >>
  • Soldiers recall carnage of Alaska WWII battle 75 years later

    Soldiers recall carnage of Alaska WWII battle 75 years later

    Sunday, May 27 2018 9:14 PM EDT2018-05-28 01:14:52 GMT
    (AP Photo/Mark Thiessen). In this May 19, 2018, photo World War II veterans Allan Seroll, left, of Massachusetts, and William Roy Dover, right, of Alabama, right, attend a 75th anniversary celebration of the Battle of Attu in Anchorage, Alaska. Dover w...(AP Photo/Mark Thiessen). In this May 19, 2018, photo World War II veterans Allan Seroll, left, of Massachusetts, and William Roy Dover, right, of Alabama, right, attend a 75th anniversary celebration of the Battle of Attu in Anchorage, Alaska. Dover w...
    One of the bloodiest World War II battles in the Pacific was waged 75 years ago this month on Attu Island in Alaska's Aleutian Islands.More >>
    One of the bloodiest World War II battles in the Pacific was waged 75 years ago this month on Attu Island in Alaska's Aleutian Islands.More >>

By BY LINDA A. JOHNSON
AP Medical Writer

TRENTON, N.J. (AP) - U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer.

The drug, called Kisqali and developed by Swiss drugmaker Novartis AG, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells.

It's for women who have metastatic breast cancer known as HR+/HER2-. About 40 percent of U.S. women diagnosed with breast cancer have this type, according to the American Cancer Society.

The U.S. Food and Drug Administration confirmed the approval on Monday. Kisqali (KISS'-kahl-lee) is taken along with an older cancer drug called letrozole that works differently.

"This is an important therapy for these patients" who have limited options, said Dr. Vas Narasimhan, chief medical officer and head of drug development at Novartis, which has its U.S. headquarters in East Hanover, New Jersey.

Kisqali, part of the drug class called kinase inhibitors, is taken daily for three weeks, followed by a one-week break. Meanwhile, patients also take either letrozole or another aromatase inhibitor, depending on the characteristics of their disease, for the entire four-week cycle.

A four-week supply of Kisqali, or 21 pills, will have a list price of $10,950 for the strongest dose - 600 milligrams. The 400-milligram dose will cost $8,760 and the 200-milligram dose $4,380, Novartis said.

Patients often need to switch doses and the smaller doses will save patients and insurance companies money. Novartis said it will offer patients several types of financial assistance and many won't have to make copayments.

A study of 668 women funded by Novartis found that Kisqali and letrozole together reduced the risk of death or the cancer worsening by 44 percent, compared to those receiving only letrozole.

Kisqali, known chemically as ribociclib, can have side effects, ranging from potentially fatal abnormal heartbeat, serious liver problems and severe infections to nausea, hair loss and fatigue. It cannot be taken by women who are pregnant or breastfeeding.

Novartis has long been a leader in developing cancer medicines. It developed Kisqali along with Astex Pharmaceuticals, a subsidiary of Japan's Otsuka Group.

Novartis said it's conducting additional Kisqali studies in combination with other treatments, and in women who haven't yet begun menopause.

Two are late-stage studies, usually the last stage before seeking regulatory approval, and results should be available late this year or early next year, the company said.

__

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • More From wfmj.comHot ClicksMore>>

  • More LGBT issues loom as justices near wedding cake decision

    More LGBT issues loom as justices near wedding cake decision

    Sunday, May 27 2018 9:07 PM EDT2018-05-28 01:07:44 GMT
    (AP Photo/J. Scott Applewhite, File). FILE - In this Oct. 10, 2017, file photo, the Supreme Court in Washington is seen at sunset. A flood of lawsuits over LGBT rights is making its way through the courts and will continue, no matter the outcome in the...(AP Photo/J. Scott Applewhite, File). FILE - In this Oct. 10, 2017, file photo, the Supreme Court in Washington is seen at sunset. A flood of lawsuits over LGBT rights is making its way through the courts and will continue, no matter the outcome in the...
    A flood of lawsuits over LGBT rights is making its way through courts and that'll continue, no matter what the Supreme Court decides in the case of a baker who wouldn't create a wedding cake for a same-sex couple.More >>
    A flood of lawsuits over LGBT rights is making its way through courts and that'll continue, no matter what the Supreme Court decides in the case of a baker who wouldn't create a wedding cake for a same-sex couple.More >>
  • Amid anti-immigrant sentiment, some Spanish speakers wary

    Amid anti-immigrant sentiment, some Spanish speakers wary

    Sunday, May 27 2018 5:27 PM EDT2018-05-27 21:27:56 GMT
    (AP Photo/Chris Carlson). Lilly Mucarsel, a native of Ecuador, poses for a picture in her office Friday, May 25, 2018, in Tustin, Calif. Mucarsel, 62, of Southern California finds herself reverting to English when she attends a baseball game or goes to...(AP Photo/Chris Carlson). Lilly Mucarsel, a native of Ecuador, poses for a picture in her office Friday, May 25, 2018, in Tustin, Calif. Mucarsel, 62, of Southern California finds herself reverting to English when she attends a baseball game or goes to...
    The Trump administration's harsh rhetoric and tougher policies toward immigrants have made some Spanish speakers self-conscious about speaking other languages in public.More >>
    The Trump administration's harsh rhetoric and tougher policies toward immigrants have made some Spanish speakers self-conscious about speaking other languages in public.More >>
  • Teacher out of hospital after stopping school shooting

    Teacher out of hospital after stopping school shooting

    Sunday, May 27 2018 3:15 PM EDT2018-05-27 19:15:37 GMT
    (Robert Scheer/The Indianapolis Star via AP). Law enforcement officers walk outside Noblesville West Middle School in Noblesville, Ind., after a shooting on Friday, May 25, 2018. A male student opened fire at the suburban Indianapolis school wounding a...(Robert Scheer/The Indianapolis Star via AP). Law enforcement officers walk outside Noblesville West Middle School in Noblesville, Ind., after a shooting on Friday, May 25, 2018. A male student opened fire at the suburban Indianapolis school wounding a...
    Authorities say a female student wounded in an Indianapolis-area middle school shooting is in critical condition and a teacher who was also shot is in good condition.More >>
    Authorities say a female student wounded in an Indianapolis-area middle school shooting is in critical condition and a teacher who was also shot is in good condition.More >>
Powered by Frankly
All content © Copyright 2000 - 2018 WFMJ. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms